ESBC
AGN

E.S. Barr & Co’s Allergan plc AGN Stock Holding History

E.S. Barr & Co’s Portfolio AGN Stock Details AGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-12,775
Closed -$1.87M – 85
2019
Q1 		$1.87M Sell
12,775
-390
-3% -$56.5K 0.19% 43
2018
Q4 		$1.76M Hold
13,165
– – 0.2% 44
2018
Q3 		$2.51M Sell
13,165
-1,035
-7% -$190K 0.25% 44
2018
Q2 		$2.37M Sell
14,200
-215
-1% -$34.5K 0.24% 46
2018
Q1 		$2.43M Buy
+14,415
New +$2.42M 0.25% 45

Other funds holding AGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return
Artisan Partners
Artisan Partners Milwaukee, Wisconsin $62.3B AUM 26.25% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
LP
Longview Partners St Peter Port, Guernsey $7.06B AUM 3.43% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

E.S. Barr & Co's AGN Position: Q2 2019 in Review

E.S. Barr & Co sold out of Allergan plc (AGN) in Q2 2019, closing a stake of 12,775 shares — an estimated $1.87M sold.

E.S. Barr & Co first reported a position in AGN in Q1 2018 and held it in 5 quarters. The position peaked at $2.51M in Q3 2018. 971 funds tracked by Wall St. Rank hold AGN as of Q2 2019.

  • E.S. Barr & Co reported no remaining Allergan plc position as of Q2 2019 after selling out during the quarter.
  • E.S. Barr & Co sold 12,775 Allergan plc shares in Q2 2019, an estimated $1.87M.
  • E.S. Barr & Co first reported a position in Allergan plc in Q1 2018 and held it in 5 quarters.
  • E.S. Barr & Co's Allergan plc position peaked at $2.51M in Q3 2018.
  • 971 funds tracked by Wall St. Rank held Allergan plc as of Q2 2019.

Based on E.S. Barr & Co's 13F filing for Q2 2019, filed 8 Aug 2019.